Prior SARS-CoV-2 infection is associated with protection against reinfection
1. Previous infection from SARS-CoV-2 was linked to an 84% lower incidence of reinfection. 2. Median interval between primary infection ...
Tag: COVID-19 antibodies
Azithromycin does not improve clinical outcomes in high-risk patients with suspected COVID-19 in the community setting
1. 80% of patients in the azithromycin plus usual care group reported feeling recovered within 28 days, compared to 77% ...
Low seroprevalence of anti-SARS-CoV-2 antibodies seen in a cross-sectional sample of residents from Wuhan, China
1. A cross-sectional sample of residents from Wuhan, China showed low overall seroprevalence (6.92%) of anti-SARS-CoV-2 antibodies in April 2020. ...
Heterologous recombinant adenovirus-based COVID-19 vaccine (Gam-COVID-Vac) is tolerable and highly efficacious
1. Efficacy of the Gam-COVID-Vac (Sputnik V) vaccine against COVID-19 was 91.6%. 2. In the vaccine group, there were no ...
Novel SARS-CoV-2 vaccine candidate SCB-2019 offers good safety profile and elicits strong humoral responses
1. Novel SARS-CoV-2 vaccine SCB-2019 was well-tolerated amongst both younger and older adults. 2. SCB-2019 adjuvanted with AS03 or CpG/Alum ...
Reduced risk of SARS-CoV-2 with presence of antibodies
1. Health care workers with anti-spike antibodies revealed no symptomatic infections during the follow-up period for at least six months. ...
#VisualAbstract: Serum antibody testing for SARS-CoV-2
1. Antibody testing to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was shown to provide diagnostic support for patients ...